Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Neoplasms × Lymph Node Excision × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 7 Lymphatic Metastasis 6 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 3 Thyroid Cancer, Papillary 2 Stomach Neoplasms 2 Postoperative Complications 2 Ovarian Neoplasms 2 Lymphedema 2 Lung Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Ureteral Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Radiation Injuries 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Platelet Glycoprotein IV Deficiency 1 Parotid Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Metastasis 1 Mixed Tumor, Mesodermal 1 Melanoma 1 Facies 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1

Interventions

Paclitaxel 12 pembrolizumab 8 Carboplatin 7 Surveys and Questionnaires 5 Docetaxel 4 Cisplatin 4 Brachytherapy 4 Gemcitabine 3 FANG vaccine 3 Doxorubicin 3 olaparib 2 durvalumab 2 Topotecan 2 Sentinel Lymph Node Biopsy 2 Saline Solution 2 Radiotherapy 2 Radiation 2 Pemetrexed 2 Music Therapy 2 Letrozole 2 Imagery, Psychotherapy 2 Hysterectomy 2 Exercise 2 CP protocol 2 Bevacizumab 2 ulipristal acetate 1 trastuzumab deruxtecan 1 temsirolimus 1 seribantumab 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02115477 2019-10-25

LASEC

University Hospital, Linkoeping

Lymphedema, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡